1037624-76-2 Usage
Description
(R)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine is a complex organic molecule with a 1H-1,2,4-triazole-3,5-diamine core structure and three distinct cyclic moieties attached to it. These moieties include a benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl, a tetrahydro-5H-benzo[7]annulen-2-yl, and a pyrrolidin-1-yl group. Due to its complex structure and potential interaction with biological systems, this compound likely possesses significant pharmacological properties.
Uses
Used in Pharmaceutical Industry:
(R)-1-(6,7-Dihydro-5H-benzo[6,7]cyclohepta[1,2-c]pyridazin-3-yl)-N3-(7-(pyrrolidin-1-yl)-6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-yl)-1H-1,2,4-triazole-3,5-diamine is used as a potential pharmaceutical candidate for various applications due to its complex structure and potential interaction with biological systems. Its specific activities and potential applications may be further explored through chemical and pharmacological research.
Used in Chemical Research:
In the field of chemical research, this compound can be used for studying the interactions between its complex structure and various biological systems. This may lead to the discovery of new mechanisms of action and potential therapeutic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 1037624-76-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,0,3,7,6,2 and 4 respectively; the second part has 2 digits, 7 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1037624-76:
(9*1)+(8*0)+(7*3)+(6*7)+(5*6)+(4*2)+(3*4)+(2*7)+(1*6)=142
142 % 10 = 2
So 1037624-76-2 is a valid CAS Registry Number.
1037624-76-2Relevant articles and documents
POLYCYCLIC HETEROARYL SUBSTITUTED TRIAZOLES USEFUL AS AXL INHIBITORS
-
Page/Page column 141, (2008/12/07)
Polycyclic heteroaryl substituted triazoles and pharmaceutical compositions containing the compounds are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the compounds in treating diseases
